Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice
Results of the Relieve Study
Datos Bibliográficos
| ID | 15519229 |
|---|---|
| Autores | Gregory W Mattingly (0000-0002-0234-6860, Political Research Associates), Hongye Ren (0000-0003-0080-4765, Lundbeck (Denmark)), Michael Cronquist Christensen (0000-0002-3605-7223, Lundbeck (Denmark)), Martin A Katzman (0000-0002-6169-2595, NOSM University), Mircea Polosan (0009-0006-3849-3981, Centre Hospitalier Universitaire de Grenoble), Kenneth Simonsen (Lundbeck (Denmark)), Lene Hammer-Helmich (0000-0001-8962-6250, Lundbeck (Denmark), autor de correspondencia) |
| Año | 2022 |
| Volumen | 13 |
| Páginas | 824831-824831 |
| Fecha de publicación | 2022-03-09 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Frontiers in Psychiatry (JOURNAL) |
| Identificadores de la revista | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Editorial | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2022.824831 |
| PMID | 35356713 |
| OpenAlex | W4221006087 |
| Idioma | EN |
| Citas recibidas | 3 |
| Referencias citadas | 73 |
These results demonstrate the effectiveness and tolerability of vortioxetine for the treatment of MDD in a large and heterogeneous patient population representative of that encountered in routine clinical practice
Adverse effect · Anxiety · Depression (economics · Depressive symptoms · Digit symbol substitution test · Generalized anxiety disorder · Major depressive disorder · Mood · Patient Health Questionnaire · Psychiatry · Tolerability · Vortioxetine · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · Medicine · Treatment of Major Depression · Tryptophan and brain disorders · Internal Medicine
Cognitive impairment in depression
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
The Arizona Sexual Experience Scale (Asex)
Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017
The PHQ-9
Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease
Differences in Perceptions of Major Depressive Disorder Symptoms and Treatment Priorities Between Patients and Health Care Providers Across the Acute, Post-Acute, and Remission Phases of Depression
| Obras citantes distintas | 3 |
|---|---|
| Citas por año | 1 |
| Intervalo de citas | 2023 - 2023 (1) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 3 |